Jessica Foglesong

Jessica Foglesong

M D Anderson Cancer Center University of Texas - Houston / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1346091
MD Anderson Cancer Center
person_outline Jessica Foglesong's MOST POPULAR ARTICLES
1-) Management guidelines for paediatric patients receiving chimeric antigen receptor T cell therapyKM Mahadeo, SJ Khazal, H Abdel-Azim, JC Fitzgerald, A Taraseviciute, ...Nature Reviews Clinical Oncology 16 (1), 45-63, 20191542019
2-) High-avidity cytotoxic T lymphocytes specific for a new PRAME-derived peptide can target leukemic and leukemic-precursor cellsC Quintarelli, G Dotti, ST Hasan, B De Angelis, V Hoyos, S Errichiello, ...Blood, The Journal of the American Society of Hematology 117 (12), 3353-3362, 20111122011
3-) Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4CR Cruz, U Gerdemann, AM Leen, JA Shafer, S Ku, B Tzou, TM Horton, ...Clinical Cancer Research 17 (22), 7058-7066, 2011952011
4-) Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphomaJA Shafer, CR Cruz, AM Leen, S Ku, A Lu, A Rousseau, HE Heslop, ...Leukemia & lymphoma 51 (5), 870-880, 2010742010
5-) The histone deacetylase inhibitor entinostat (SNDX-275) induces apoptosis in Hodgkin lymphoma cells and synergizes with Bcl-2 family inhibitorsÁ Jóna, N Khaskhely, D Buglio, JA Shafer, E Derenzini, CM Bollard, ...Experimental hematology 39 (10), 1007-1017. e1, 2011662011